Abstract
BackgroundThe use of unlicensed and off-label medicines is common within neonatal intensive care.1 Their use presents challenges, including inconsistent supply, high cost and lack of information together with increased risk...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have